Gregory P. Madison
2017
In 2017, Gregory P. Madison earned a total compensation of $2.9M as Former Chief Executive Officer and President at Keryx Biopharmaceuticals, a 44% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $317,475 |
|---|---|
| Option Awards | $1,187,820 |
| Salary | $556,305 |
| Stock Awards | $829,500 |
| Other | $7,604 |
| Total | $2,898,704 |
Madison received $1.2M in option awards, accounting for 41% of the total pay in 2017.
Madison also received $317.5K in non-equity incentive plan, $556.3K in salary, $829.5K in stock awards and $7.6K in other compensation.
Rankings
In 2017, Gregory P. Madison's compensation ranked 3,767th out of 14,666 executives tracked by ExecPay. In other words, Madison earned more than 74.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,767 out of 14,666 | 74th |
Division Manufacturing | 1,312 out of 5,768 | 77th |
Major group Chemicals And Allied Products | 367 out of 2,074 | 82nd |
Industry group Drugs | 283 out of 1,730 | 84th |
Industry Pharmaceutical Preparations | 224 out of 1,329 | 83rd |
Source: SEC filing on May 31, 2018.
Madison's colleagues
We found four more compensation records of executives who worked with Gregory P. Madison at Keryx Biopharmaceuticals in 2017.